ESG AND SUSTAINABILITY
Remgro is committed to developing an
environmental,
social and governance (ESG) strategy that reflects South
Africa's unique sustainability challenges and to
address the opportunities and risks they present.
This report sets out our Remuneration Policy and Remuneration Implementation Report for executive directors and non-executive directors’ remuneration for the 2022 financial year and is presented in three parts:
| i) | Part 1: The background statement which provides context to our Remuneration Policy and performance; |
| ii) | Part 2: An overview of the forward-looking Remuneration Policy applicable in the 2023 financial year; and |
| iii) | Part 3: The Remuneration Implementation Report which sets out in detail how the existing policy was implemented during the year under review, including disclosure on payments made to executive directors and non-executive directors during the year ended 30 June 2022. |
Remgro’s remuneration philosophy is guided by its business strategy, namely a long-term approach to deliver value in a sustainable manner.
Due to the nature of the business, the remuneration framework, on an organisation-wide basis, provides for Financial (i.e. salary and benefits) and a long-term share plan, which only renders value if the stretching performance conditions (where applicable) and the employment condition are met. As an investment holding company, the Remuneration and Nomination Committee (the committee) views increased market capitalisation, sustainable growth in the share price and above-average dividend yield as critical metrics to deliver value to shareholders over time. In line with this approach, Remgro does not pay short-term incentives (i.e. cash bonuses) and believes that management’s decision-making should be long-term focused. It is aligned with the philosophy that they should be rewarded where value creation is demonstrated, without excessive risk taking in the short term. This two-tier approach makes the Remgro Remuneration Policy focused and avoids unnecessary layers of complexity. Our remuneration philosophy and policy are further detailed in Part 2 of this report.
Remgro has a diversified portfolio of investments across industries, which include healthcare, consumer products, financial services, infrastructure, industrial, and media interests.
This first half of the 2022 financial year continued to be a volatile journey, with the fallout of the July violent unrest and the threat of the fourth wave of the Covid-19 pandemic, amidst a slow vaccination progress, which saw the global community impose further travel bans on South Africa. As we began to emerge and recover, renewed macro challenges and volatility were evident on a global scale.
During the second half of the 2022 financial year, the Russian invasion of the Ukraine negatively influenced global and local economies through increased food and energy costs and rising inflation in developed economies to levels not experienced in the last 10–15 years. The persistent increase in inflation and interest rates caused renewed concerns of a recession in these developed markets. Domestically, the rise in the price of fuel, persistent loadshedding, the general demise of infrastructure, increased prevalence of natural disasters and the possibility of a global recession continue to inhibit our economic recovery.
Remgro continues to focus on its processes curated over its 74-year rich history, remaining committed to its strategic priorities, its corporate citizen mandate and values-driven ethos. To this end, significant progress has been made in the reporting period on strategic initiatives as Remgro continues to position itself for the future. Transformative corporate actions to this effect include the recently announced Mediclinic International plc (Mediclinic), Distell Group Holdings Limited (Distell), Community Investment Ventures Holdings Proprietary Limited (CIVH) and Rand Merchant Investment Holdings Limited (RMI) transactions.
Remgro’s commitment to its investment philosophy and underlying investments has seen a robust recovery in financial performance compared to the previous period with the majority of financial metrics ahead of pre-pandemic levels. Remgro is more than encouraged that its prudent management, strong balance sheet and capital allocation track record (as evidenced by its resilient portfolio) have enabled it to deliver a quick recovery amidst all the headwinds.
In line with Remgro’s philosophy on fair and responsible remuneration, the following decision was taken with regards to increases:
The vesting outcomes for the 2019 LTI awards, for which the performance period ended during the 2022 financial year, were 71%. Details on the vesting of these awards are set out in Part 3 of this report.
Remgro aims to be the trusted investment company of choice that consistently creates sustainable stakeholder value. While workplace, economic, social and environmental sustainability practices have always been part of Remgro’s core values and are entrenched within Remgro’s overall governance framework, Remgro aims to become an ESG leader and is placing increased emphasis on ESG practices.
Remgro’s size and influence as an investment holding company enables it to acquire significant interest in entities that are big enough to have a material effect on Remgro’s results. As Remgro’s business and investment philosophy is centred around investing in businesses that are aligned with its values and purpose, this places Remgro in the position to influence the implementation of an ESG strategy and the entrenchment of ESG frameworks across the Group.
To this end, Remgro embarked on an ESG journey in 2021, the aim of which is to develop a strong ESG strategy and framework for implementation across the business and the businesses of investee companies. Within the Remgro holding company, appropriate strategic and operational ESG committees and work groups were established in 2021 to ensure that Remgro remains engaged with its corporate citizen mandate and values-driven ethos. As part of our future focus, and in order to maximise our ESG impact, Remgro as a holding company will focus on influencing our investee companies to adopt a similar focused strategic and operational focus on ESG.
To incentivise and motivate management in driving this journey, qualitative ESG measures were incorporated into the Remgro Long Term Incentive Scheme (LTIs) in 2021 which measures detailed strategic milestones to be achieved by specified dates. By incorporating specific ESG measures into the LTI, Remgro is illustrating its public commitment to ESG. The first LTI awards with the ESG measures were awarded in 2020 (being the 2019 and 2020 LTI awards). An overview of the outcomes of these qualitative measures is reflected below:
| 1. | Management successfully executed the specific targets set at threshold and target levels in full and on time. These included the following:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
| 2. | The stretch target to influence key subsidiary companies to have ESG targets and key performance initiatives (KPIs) for LTI and/or short-term incentive (STI) plans at executive level were partially achieved.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
| 3. | In addition to the achievement of the agreed targets, the following additional outcomes and context are important to note:
|
It is the committee’s view that the specific qualitative targets were suitably challenging, aligned with the Company’s strategy and laid a solid foundation upon which the Company can deliver on its ESG ambition.
As indicated in the 2021 report, due to the ESG journey being in its infancy, the committee set qualitative ESG measures (30% of the ESG component – threshold performance) for the first year of the performance period of the 2021 LTI award, which measures were aimed at establishing the foundation on which quantitative measures could be included. Following on the foundation created by these and the above qualitative measures linked to the 2019 and 2020 LTI awards, the committee was in the position to set the quantitative measures for the remaining two years of the performance period for the 2021 LTI award as well as for the 2022 LTI award which will be made in December 2022. This is set out in more detail in Part 2. It is important to note that from a quantitative measure perspective, Remgro evaluated where they can deliver the most significant portfolio impact and in which form. After careful deliberation, considering our investment philosophy of providing support and strategic guidance to investee companies (while not being involved in the day-to-day operation of our investee companies in line with our philosophy of decentralised management), we identified that the most significant impact which Remgro can deliver is to provide support and guidance in the implementation of an ESG framework and strategy within the identified group of investee companies. Consequently, the quantitative measures consider Remgro’s success rate in being able to deliver on this impact, expressed as a governance/influence factor.
More details are provided in Parts 2 and 3 of this report.
At the Annual General Meeting (AGM) held on 25 November 2021, 69.9% of Remgro’s ordinary shareholders voted in favour of the Remuneration Policy, with 88.2% of ordinary shareholders voting in favour of the Remuneration Implementation Report. In light of the fact that more than 25% of ordinary shareholders voted against the remuneration policy, and in compliance with King IV and the JSE Listings Requirements, dissenting shareholders were invited to engage with the Company. Shareholders were provided further focused engagement opportunities through virtual engagement sessions during our shareholder engagement roadshows.
The specific areas of concern, together with actions taken as a result of the issues raised, are listed in more detail below.
Shareholder concern |
Action taken/Remgro’s response |
||||||
|
Remuneration Policy Timeline as to when the quantifiable ESG metrics will be introduced |
The intention
of the committee and management was to introduce quantifiable ESG metrics as soon as practically
possible. For this purpose, the target and stretch measures for the 2021, 2022 and beyond were not
disclosed in the 2021 Remuneration Report. As a holding company Remgro is not fully aware of the ESG
maturity levels at different investee companies and the baseline measures for key ESG measures at
these companies.
Once the Company fully understand the ESG landscape across investee companies and we are able to articulate and commit to meaningful quantitative ESG measures those will be added to the 2021 and 2022 awards. |
||||||
| Adjustment to expiry dates of in-flight awards | All the LTI
awards affected by the extended expiry dates relate to the Share Appreciation Rights scheme (SARs)
awards made to participants during 2013, 2014 and 2015. With the extended expiry dates the actual
share price still needs to exceed the award price for value to be created for participants AND the
requirement that participants must be in service or regarded as a “good leaver” to remain eligible
to exercise their options under the plan rules. It is important to note the following as some of the
reasons the committee considered when they approved the extension of the expiry dates:
|
||||||
| Targeting guaranteed remuneration to the upper quartile is not best practice and shareholders are not clear who the peers are in the Mercer survey. | With regards to
the comment on the Remgro philosophy to target the upper quartile, it is important to note the
following:
Management shared the list of participating companies in the Mercer Top Executive survey with the shareholders. |
||||||
| Should the long serving non-executive directors still be regarded as independent | The committee believes on a substance over
form basis that these long-serving non-executive directors can still be regarded as independent. The
committee and the Board are satisfied that their independence is in no way affected by their length
of service.
In addition, the committee’s view is that the overriding concern should not be one of enforcing alignment or seeking independence at all costs but should be whether the governing body is knowledgeable, skilled, experienced, diverse and independent enough to discharge its roles and responsibilities fully. |
||||||
Remuneration is key in incentivising employees across all levels to work towards driving the execution of Remgro’s strategic objectives and to build a sustainable business over the long term. The committee remains committed to ongoing engagement with shareholders and welcomes any constructive feedback they may wish to provide to ensure that the Company’s approach to remuneration supports fair and responsible remuneration.
At the 2022 AGM Remgro will put its Remuneration Policy and Remuneration Implementation Report to two separate nonbinding advisory shareholder votes (see Ordinary Resolutions Numbers 13 and 14 in the Notice to shareholders) and the committee looks forward to a positive outcome in this regard.
The committee’s activities for 2022 were geared towards monitoring the achievement of Remgro’s strategic objectives. In addition to the committee’s normal duties, the committee:
During the 2023 financial year the committee will focus on the following forward-looking considerations:
During the 2022 financial year, the committee has engaged external remuneration consultant PricewaterhouseCoopers Inc. (PwC), management and the Board in conducting their duties and responsibilities.
The committee considered the advice, opinions and services received by PwC during the 2022 financial year. The committee is satisfied and regards PwC as being wholly objective and independent.
The committee is of the view that during the 2022 financial year, Remgro’s Remuneration Policy achieved its stated objectives. Remgro constantly strives to improve the Company’s remuneration practices and we look forward to our engagement with our shareholders and receiving their support on the resolutions for both the Remuneration Policy and Remuneration Implementation Report (see Ordinary Resolutions Numbers 13 and 14 in the Notice to shareholders) at the AGM on 30 November 2022.
The Remuneration Policy provides an overview of Remgro’s remuneration principles for the organisation as a whole and applies to all permanent employees. The information provided in this policy has been approved by the Board on recommendation by the committee. This Remuneration Policy will be put to a non-binding advisory vote by shareholders at the next AGM on 30 November 2022.
The committee is appointed by the Board with delegated powers and the functioning of this dedicated Board committee is well established within Remgro’s mode of operation. In essence it is the committee’s role to ensure fair and responsible remuneration across the Company, by way of policy making and implementation, and that the disclosure of remuneration is accurate, complete and transparent. Ultimate responsibility remains with the Board.
The committee is governed by a mandate, reviewed and approved by the Board annually, that incorporates best practice governance recommendations and serves to assist members of this committee in the execution of their role and responsibilities.
The committee consists of four non-executive directors, three of whom are independent. The members of the committee for the year under review were:
The Board acknowledges the recommended practice in King IV that the Chairman of the Board should not be the chairman of this committee but given the following reasons, this arrangement is deemed appropriate:
The committee formally met twice during the year and had numerous informal interactions in preparation for the formal meetings. The details on the attendance of the formal meetings are set out in the Corporate Governance Report.
The mandate set out in the terms of reference of the committee includes the following:
In respect of its nomination function –
In respect of its remuneration function –
Workplace, economic, social and environmental sustainability practices have always been part of Remgro’s core values and through our new ESG strategy, these practices are entrenched within our overall remuneration framework.
Link to ESG |
Link to reward |
||||||
| Environmental | Inclusion of ESG measures within the LTI plans Individual KPIs include specific ESG measures |
||||||
| Social | TGP of non-management employees is competitive and is positioned around the 75th percentile of the market All employees participate in the LTI plan Lower-level employees typically receive higher percentage increases |
||||||
| Governance | Balancing employee interests with that of shareholders by rewarding for the delivery of growth in INAV Aligning to international best practice by incorporating malus and clawback provisions into variable pay Clear and transparent remuneration reporting Development of an ESG governance framework |
||||||
As noted in Part 1 of this report, Remgro’s aim is to become an ESG leader and is focused on maximising its impact as an investment holding company by establishing and rolling out an ESG strategy and governance framework throughout the Group of identified investee companies. Remgro commenced its ESG journey in 2021.
In order to drive the execution of this goal and to ensure that it is sufficiently prioritised, ESG measures were introduced into the LTIs in 2021 as a non-financial component with a weighting of 20%. The ESG measures for the 2019 and 2020 awards were qualitative measures focused on governance and risk as well as strategic investment decisions and portfolio impact and which detailed milestones to be achieved by specified dates in order to lay the foundation for the establishment and implementation of an ESG strategy throughout the Group.
Building on the foundation laid through delivery on the qualitative milestones, Remgro has introduced quantitative ESG measures, taking the form of a governance influence factor (as referenced in Part 1 above), into the 2021 and 2022 LTIs which measures are aimed at establishing the appropriate ESG governance structures within key investee companies.
The delivery of Remgro’s strategy is dependent on the values, talent and skills of all employees across the Company and Remgro therefore views employees as critical assets. Remgro committed to the principle of rewarding all employees across the Company in a manner which is fair and responsible and strives to create an environment which is inclusive. This commitment is entrenched in the remuneration policy.
The TGP of all employees is positioned around the 75th percentile of the market which takes into account that the Company does not have a STI in place. All employees are furthermore eligible to receive LTI awards and not only executives. Lower-level employees typically receive higher percentage increases than other employees.
Further ongoing actions taken in this regard include:
Remgro has two components of remuneration, namely fixed remuneration (which includes benefits) and LTIs in the form of its old Remgro Equity Settled Share Appreciation Right Scheme (SAR Scheme), current Remgro Equity Settled Share Appreciation Rights Plan (SAR Plan) and Remgro Equity Settled Conditional Share Plan (CSP). Remgro does not pay short-term incentives and believes that management’s decision-making should be long-term focused and aligned with the philosophy that they should be rewarded where long-term value creation is demonstrated, without excessive risk taking in the short term.
The same remuneration principles and components apply to all employees of Remgro. The remuneration policies, principles and practices of investee companies are governed through remuneration committee structures in these organisations.
Fixed remuneration |
Purpose |
|
To provide competitive fixed remuneration that will attract and retain appropriate talent. Reflects an individual’s responsibilities,
experience and role.
|
What does this contain? |
|
Referred to as TGP, includes components such as cash salary, travel allowance and the Company’s contributions towards retirement funding and the medical scheme. All guaranteed benefits are funded from the TGP. Retirement funding contributions range between 18.5% and 27.5% of pensionable emolument and the key features of the retirement fund are as follows:
Membership to a medical scheme is compulsory for all employees and contributions are funded from their TGP. All employees are eligible for membership of the in-house medical scheme, Remedi, and the scheme provides three different options for members to choose from annually. These options aim to accommodate the different healthcare needs and affordability of the diverse membership of the scheme. Under specific circumstances Remgro also offers employees post-employment medical benefits. All details in this regard are disclosed in the Annual Financial Statements. Only employees who are required to regularly travel for business purposes receive travel allowances, which is funded from their TGP. |
How is the TGP benchmarked? |
|
Guaranteed packages for all employees are benchmarked against the upper quartile of the market for comparable companies utilising independent salary surveys. Remgro currently makes use of the Mercer Top Executive survey for the Management Board members and senior executives. For the rest of the organisation the REMchannel national survey is used. The services of an independent remuneration consultancy are contracted for this purpose. The TGP is positioned competitively to the market to ensure that the right talent is attracted and retained. It further supports the remuneration approach of no short-term cash bonuses and discourages excessive risk taking which may be driven by leveraged cash bonuses. |
Annual review process |
|
The committee conducts an annual review of the TGP for executives and approves the increase percentage for employees below executive level. Adjustments to the TGP depends upon the employee’s level of responsibility and his/her overall performance. The CEO, who attends all committee meetings by invitation, may propose increases to the TGP, excluding his own, during such review meetings. |
Variable remuneration |
Share Appreciation Rights Plan |
Conditional Share Plan |
Purpose |
|
Ensures alignment between personal wealth creation and corporate strategy and supports long-term employee retention.
|
How does it work? |
|
This is an equity settled plan whereby selected employees are awarded rights to receive shares equal to the long-term growth in the Remgro share price and market capitalisation of the Company. These rights are awarded free of charge. The ultimate vesting of shares will be subject to prospective performance conditions for selected participants as well as an employment condition. The participants will only become shareholders in Remgro with shareholder rights, including dividend and voting rights, on the settlement date. |
This is an equity settled plan under which all employees may be granted an award consisting of the conditional right to receive Remgro shares at a future point in time. These conditional shares are awarded free of charge. The ultimate vesting of shares will be subject to prospective performance conditions for selected participants as well as an employment condition. The participants will only become shareholders in Remgro with shareholder rights, including dividend and voting rights, on the settlement date, which will be shortly after the vesting date. |
Who qualifies to participate? |
|
The SAR Plan is currently used to incentivise executive directors and employees at senior executive level only.
|
All permanent employees of the Company may participate in the CSP.
|
Determination of value/allocation |
|
The committee makes annual awards in terms of the SAR Plan and the CSP to participants, based on a multiple of TGP. The set annual multiples are determined by reference to a participant’s job grade, role, the need to attract and/or retain key talent and the value added by the participant for Remgro and shareholders. The face value award multiples are as follows:
For all other participants, 100% of the award is under the CSP. The vesting of these awards is subject to continued employment only. These multiples are within current market parameters. In addition, the rules of the CSP allow for ad hoc awards to be made to participants in exceptional circumstances as determined by the committee. Refer to the Remuneration Implementation Report here for previous SARs and CSPs awarded. |
Dividend equivalents |
|
Not applicable.
|
Participants will be eligible to receive dividend equivalents on vested shares at the end of the vesting period of the ward. The dividend equivalent will be rolled up over the vesting period and delivered as additional shares on the vesting date. |
Vesting and exercise/settlement |
|
Participants in the SAR Plan are remunerated with Remgro shares to the value of the appreciation of their rights to a specific number of Remgro ordinary shares. The earliest intervals at which the SARs vest and are exercisable are as follows:
All SARs must be exercised within seven years after the grant date, upon which date unexercised SARs lapse. Vesting is conditional on fulfilment of the employment period and achievement of performance conditions (where applicable). |
Awards under the CSP will vest as follows:
Vesting is conditional on fulfilment of the employment period and achievement of performance conditions (where applicable).
|
Performance conditions |
|
The SAR Plan has an embedded performance hurdle whereby participants will only benefit if there is long-term share price appreciation and thus value creation for Remgro shareholders. 2021 Award An overview of the financial and non-financial performance measures for the 2021 SAR and CSP awards are set out below: Financial
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Performance measure |
Weight |
Threshold (vesting 30%)* |
On-target (vesting 50%)* |
Stretch (vesting 100%)* |
|
INAV |
55% |
Year one INAV plus CPI over |
Year one INAV plus the 3 – 5 year SA |
Year one INAV plus the 3 – 5 year SA Longbond rate plus 5% over three financial years |
|
Free cash flow (FCF) |
25% |
Year one FCF plus CPI over |
n/a |
Year one FCF plus CPI plus 1.25% over three financial years |
| * | For performance between these points linear vesting will apply. |
|
Performance measure |
Weight |
Threshold (vesting 30%)* |
On-target (vesting 50%)* |
Stretch (vesting 100%)* |
|||
|
ESG |
20% |
The following needs to be achieved by June 2023:
|
The following needs to be achieved by 31 December 2023:
|
The following needs to be achieved by 30 June 2024:
|
|||
| * | For performance between these points linear vesting will apply. | ||||||
| ** | The number of companies can change over time because of corporate activities. Strategy to remain focused on around 80% of INAV. | ||||||
| *** | Through these targets the Company will influence proper governance, reporting and measurements of ESG activities. | ||||||
|
In addition, the vesting of awards can be modified based on the extent to which the participant meets their individual performance conditions. Note that the achievement of these individual performance conditions can only reduce the result of the overall financial and non-financial ESG performance conditions. Awards will only vest if the participant remains in service of the Remgro Group. |
|||||||
|
During the 2023 financial year, the committee will consider the award of further SAR and CSP awards as well as the performance conditions to be aligned with these awards. These awards will be considered with consideration to the approved rules. The committee will review the current financial and non-financial conditions to ensure they remain relevant, stretching and continue to focus management’s efforts on the appropriate measures. The committee will, amongst others, consider the following when setting the performance conditions: |
|||||||
| 1 | The measures to determine outperformance of the financial performance conditions. |
||||||
| 2 | To ensure the non-financial ESG measures continue to stretch management and focus the Company to drive the ESG ambitions as articulated in this report and the separate Sustainability Report. These could include:
|
||||||
|
These performance conditions will apply to executive directors and other members of the Management Board (prescribed officers) in respect of SAR Plan awards and to executive directors, other members of the Management Board (prescribed officers) and identified investment executives in respect of CSP awards. |
|||||||
|
All other participants to the CSP will be allocated retention awards and will have to be in the service of the Remgro Group upon vesting. |
|||||||
Early termination of employment |
|
Participants may either be classified as “bad leavers” or “good leavers” and the following applies:
|
Change of control |
|
In the event of a change of control of the Company occurring before the vesting date of any award, a portion of the award held by a participant will vest as soon as reasonably practicable thereafter. The portion of the award which shall vest will be determined based on the number of months served from the award date to the change of control date, over the total number of months in the vesting period and the extent to which the performance condition(s), if applicable, have been met. Any awards which do not vest will, subject to the discretion of the committee, remain subject to the terms of the relevant award letter. |
Variation in share capital |
|
Participants shall continue to participate in the SAR Plan and the CSP in the event of a variation in the Company’s share capital. The committee may make such adjustment to the award or take such other action to place participants in no worse position than they were prior to the happening of the relevant event and to provide that the fair value of the award immediately after the event is materially the same as the fair value of the award immediately before the event. |
Dilution limits |
|
Individual basis Overall basis |
Settlement considerations |
|
If it is assumed that all of the participants to the SAR Plan exercise all options awarded to them on 1 July 2022, Remgro will have to deliver 351 092 shares in order to settle its obligations. This calculation is based on Remgro’s closing share price on 30 June 2022 of R129.91. A 10% increase or decrease in the Remgro share price will require the number of shares to be delivered to be 476 337 shares and 250 415 shares, respectively. |
If it is assumed that all awards made under the CSP vest on 1 July 2022 in full, Remgro will have to deliver 2 757 424 shares in order to settle its obligations.
|
|
On 30 June 2022 Remgro held sufficient treasury shares to settle its obligations to deliver shares to LTI participants. |
The following illustrations depict the pay mix and the possible remuneration outcomes for the CEO, Chief Financial Officer and the prescribed officer average at minimum, on-target and stretch levels.
Element |
Minimum |
On-target |
Stretch |
||||
| TGP |
TGP for 2022 |
|
|||||
| LTI |
Nil |
The number of instruments granted in the 2021 financial year (in respect of the 2020 award) that will vest if target performance (50%) is achieved, multiplied by the fair value (on grant date). |
The number of instruments granted in the 2021 financial year (in respect of the 2020 award) that will vest if full performance (100%) is achieved, multiplied by the face value (on grant date). | ||||

The Malus and Clawback Policy applies from 1 July 2021 to all new LTI awards.
The committee, in its discretion, may, in terms of the Malus and Clawback Policy, apply Malus and/or Clawback mechanisms to the LTI awards where a trigger event as provided for in the policy has occurred. Malus is applied to reduce awards where the trigger event is discovered before vesting or settlement of an award, whereas Clawback is used to recoup all or a portion of settled awards where a trigger event is discovered within three years post-vesting or settlement.
Trigger events include but are not limited to circumstances where any one or more of the following events have occurred:
Executive directors and members of the Management Board do not have fixed-term contracts, but are employed in terms of the Company’s standard contract of employment applicable to all employees. The notice period for termination of service is one calendar month and the normal retirement age is 63. Executive directors and members of the Management Board also do not have exceptional benefits associated with the termination of their services. Upon termination of employment, any payments made to employees will be as required in terms of legislation, and the consequences in respect of unexercised SARs and/or unvested CSP awards will be governed by the rules of the SAR Plan (or previous SAR Scheme) and CSP based on the reasons for the termination of employment.
Independent non-executive directors do not have any employment contracts, do not receive any benefits associated with permanent employment and do not participate in the Company’s LTI plans.
Furthermore, they are categorised as independent on the basis that the Board concludes that they have no interest, position, association or relationship which, judged from the perspective of a reasonable and informed third party, is likely to influence unduly or cause bias in decision-making in the best interest of the Company.
The independence of independent non-executive directors is reviewed annually and the independence of non-executive directors, who have served on the Board for more than nine years, is subject to a rigorous review by the Board. The Board, led by the Lead Independent Director, considered the independence of the independent non-executive directors, and is satisfied with their independence, including the independence of Messrs F Robertson (appointed 28 March 2001), M Morobe (appointed 18 June 2007), N P Mageza (appointed 4 November 2009) and P J Moleketi (appointed 4 November 2009) who each has served on the Remgro Board for more than nine years. Based on an evaluation of the aforementioned directors, there is no evidence of any circumstances or relationships that will impair their judgement, and the Board is satisfied that their independence is in no way affected by their length of service.
Independent non-executive directors are paid a fixed annual Board fee. Committee fees are also determined on a fixed annual basis. The fee structure is reviewed annually on 1 July, based on independent market benchmarks for non-executive directors’ fees, taking into account the nature and size of Remgro’s operations. Remgro utilises the Mercer NED survey to benchmark the remuneration levels of non-executive director fees. The trends identified in this survey are then validated through a focused secondary survey among a selected group of companies. Non-executive director fees are approved by shareholders at the Company’s AGM by special resolution prior to payment. Remgro also pays for all travelling and accommodation expenses reasonably and properly incurred in order to attend meetings.
Messrs J P Rupert, A E Rupert, P J Neethling and J Malherbe are regarded as non-independent non-executive directors.
The Chairman, Messrs A E Rupert and P J Neethling receive no emoluments or fees from Remgro, whilst Mr J Malherbe receives the approved annual Board and committee fees paid to Independent non-executive directors.
As in the case of Independent non-executive directors, these directors do not participate in the Company’s LTI plans.
The proposed fee structure payable to non-executive directors for the year ending 30 June 2023 is presented in the table below. Also see Special Resolution Number 1 in the Notice to shareholders.
| Type of fee (Rand) | Current fee for the year ended 30 June 2022 |
Proposed fee for the year ending 30 June 2023 |
% Change |
| Board member | 390 000 | 413 400 | 6% |
|---|---|---|---|
| Chairman of the Audit and Risk Committee | 320 760 | 340 000 | 6% |
| Member of the Audit and Risk Committee | 159 300 | 168 800 | 6% |
| Member of the Remuneration and Nomination Committee | 70 740 | 75 000 | 6% |
| Chairman of the Social and Ethics Committee | 129 600 | 137 400 | 6% |
| Member of the Social and Ethics Committee | 70 740 | 75 000 | 6% |
| Meeting fee for ad hoc Committees (i.e. Investment, Valuation, etc. committees) | 30 000 | 31 800 | 6% |
| Fees are excluding VAT. |
The Remuneration Policy and Remuneration Implementation Report are respectively tabled for separate non-binding advisory votes by the shareholders at each AGM.
The committee will engage with shareholders in the event of a 25% or more dissenting vote on either or both the Remuneration Policy and Remuneration Implementation Report. In that event, the Company will, in its voting results announcement provide for (1) an invitation to dissenting shareholders to engage with the Company, and (2) the manner and timing of such engagement. In this regard the Company intends to (1) invite the dissenting shareholders to provide the Company with their written submissions as to why they voted against the Remuneration Policy or Remuneration Implementation Report, (2) address the legitimate and reasonable objections of dissenting shareholders, and (3) report back to the dissenting shareholders. If appropriate and practical, the Company may engage with dissenting shareholders either individually or collectively at meetings called for that purpose. Other methods of shareholder engagement may include conference calls, emails and investor roadshows.
The Remuneration Implementation Report provides details on how Remgro implemented its Remuneration Policy during the 2022 financial year. (The information here was audited). This Remuneration Implementation Report will be put to a non-binding advisory vote by shareholders at the next AGM on 30 November 2022.
During the year under review, the executive directors and other members of the Management Board and senior executives received an average salary increase of circa 4.25%. Management employees received an average increase of 4.50% while nonmanagement level employees received an average increase of 5.00%.
Remgro’s Remuneration Policy does not provide for any shortterm incentives, therefore no outcomes are reported in terms of this.
The performance outcomes for the 2019 LTI award are set out below. As communicated in our 2021 report, the 2019 LTI award is the first award which incorporates ESG performance measures. These measures take the form of qualitative ESG milestones, aimed at driving the momentum and success of our ESG journey, and primarily focused on governance, risk and strategic investment decisions as well as portfolio impact.

The LTI outcomes for the year were as follows:
Performance
|
Weight |
Base
|
Threshold
|
On-target
|
Stretch
|
Actual
|
Actual
|
|||||||||
| INAV Performance hurdles and outcome (Rand per share) |
Year one INAV plus CPI over three financial years |
Year oneINAV plus the 3 – 5 year
SA Longbond rate over three financial years |
Year one INAV plus the 3 – 5 year SA Longbond rate plus 5% over three financial years | |||||||||||||
|
55% |
154.47 |
169.04 |
178.71 |
195.71 |
213.10 |
100% |
||||||||||
| FCF Performance hurdles and outcome (cents per share) |
|
|
Year one FCF plus CPI over three financial years |
n/a | Year one FCF plus CPI plus 1.25% over three financial years |
|
|
|||||||||
|
25% |
396.2 |
843.9 | n/a |
859.3 |
430.2 |
0% |
||||||||||
Performance
|
Weight |
Threshold
|
On-target
|
Stretch
|
||||||
| ESG | 20% |
The following needs to be achieved by December 2021:
|
The following needs to be achieved by 30 June 2022:
|
The following needs to be achieved by 31 December 2022:
|
||||||
| Actual performance |
100% achieved |
100% achieved |
80% achieved |
|||||||
LTI vesting |
||||||||||
LTI vesting outcome
|
LTI vesting outcome
|
LTI vesting outcome (total) |
||||
| 55% |
16% |
71% |
||||
The tables below provide information on a director and prescribed officer basis of SARs granted and accepted during the year and the indicative value of SARs not yet exercised (outstanding SARs). It also illustrates the cash value of SARs exercised during the year.
| Participant | Offer date(1) |
Offer price(2) (Rand) |
Number of SARs offered and accepted |
Fair value of SARs on offer date (R’000) |
Balance of SARs accepted as at 30 June 2021 |
Adjusted offer price(3) (Rand) |
SARs accepted/ (exercised or expired) during the year |
Share price on exercise date (Rand) |
Cash value of SARs exercised during the year(4) (R’000) |
Balance of SARs accepted as at 30 June 2022(5) |
Fair value of SARs as at 30 June 2022(6) (R’000) |
| Executive | |||||||||||
| J J Durand | 29-Nov-12(7) | 147.25 | 271 258 | 10 763 | 271 258 | 94.22 | 271 258 | 10 614 | |||
| 04-Dec-13(7) | 191.70 | 93 128 | 5 064 | 93 128 | 127.40 | 93 128 | 1 597 | ||||
| 26-Nov-14(7) | 253.53 | 108 468 | 7 442 | 108 468 | 164.57 | 108 468 | 535 | ||||
| 24-Nov-15(7) | 272.00 | 192 676 | 15 591 | 192 676 | 170.38 | 192 676 | 823 | ||||
| 01-Dec-16 | 209.11 | 150 872 | 10 554 | 150 872 | 125.95 | 150 872 | 2 561 | ||||
| 14-Dec-17 | 206.35 | 132 309 | 9 705 | 132 309 | 118.86 | 132 309 | 2 918 | ||||
| 05-Dec-18(8) | 205.07 | 87 135 | 5 436 | 87 135 | 112.38 | (87 135) | – | – | |||
| 05-Dec-20(9) | 93.82 | 235 427 | 6 111 | 235 427 | 93.82 | 235 427 | 7 415 | ||||
| 05-Dec-20 | 93.82 | 235 454 | 6 631 | 235 454 | 93.82 | 235 454 | 8 300 | ||||
| 05-Dec-21 | 126.99 | 181 379 | 7 853 | – | 126.99 | 181 379 | 181 379 | 5 362 | |||
| M Lubbe | 29-Nov-12(7) | 147.25 | 13 961 | 554 | 13 961 | 94.22 | 13 961 | 546 | |||
| 04-Dec-13(7) | 191.70 | 7 444 | 405 | 7 444 | 127.40 | 7 444 | 128 | ||||
| 26-Nov-14(7) | 253.53 | 4 011 | 275 | 4 011 | 164.57 | 4 011 | 20 | ||||
| 24-Nov-15(7) | 272.00 | 8 036 | 650 | 8 036 | 170.38 | 8 036 | 34 | ||||
| 01-Dec-16 | 209.11 | 65 632 | 4 591 | 65 632 | 125.95 | 65 632 | 1 114 | ||||
| 14-Dec-17 | 206.35 | 15 481 | 1 136 | 15 481 | 118.86 | 15 481 | 341 | ||||
| 05-Dec-18(8) | 205.07 | 14 648 | 914 | 14 648 | 112.38 | (14 648) | – | – | |||
| 05-Dec-20(9) | 93.82 | 39 078 | 1 014 | 39 078 | 93.82 | 39 078 | 1 231 | ||||
| 05-Dec-20 | 93.82 | 46 448 | 1 308 | 46 448 | 93.82 | 46 448 | 1 637 | ||||
| 05-Dec-21 | 126.99 | 35 796 | 1 550 | – | 126.99 | 35 796 | 35 796 | 1 058 | |||
| N J Williams | 29-Nov-12(7) | 147.25 | 81 901 | 3 250 | 81 901 | 94.22 | 81 901 | 3 205 | |||
| 04-Dec-13(7) | 191.70 | 22 221 | 1 208 | 22 221 | 127.40 | 22 221 | 381 | ||||
| 26-Nov-14(7) | 253.53 | 16 430 | 1 127 | 16 430 | 164.57 | 16 430 | 81 | ||||
| 24-Nov-15(7) | 272.00 | 27 492 | 2 225 | 27 492 | 170.38 | 27 492 | 117 | ||||
| 01-Dec-16 | 209.11 | 98 716 | 6 905 | 98 716 | 125.95 | 98 716 | 1 675 | ||||
| 14-Dec-17 | 206.35 | 55 677 | 4 084 | 55 677 | 118.86 | 55 677 | 1 228 | ||||
| 05-Dec-18(8) | 205.07 | 28 465 | 1 776 | 28 465 | 112.38 | (28 465) | – | – | |||
| 05-Dec-20(9) | 93.82 | 72 103 | 1 871 | 72 103 | 93.82 | 72 103 | 2 271 | ||||
| 05-Dec-20 | 93.82 | 72 124 | 2 031 | 72 124 | 93.82 | 72 124 | 2 542 | ||||
| 05-Dec-21 | 126.99 | 55 568 | 2 406 | – | 126.99 | 55 568 | 55 568 | 1 643 | |||
| Total | 2 196 595 | 142 495 | – | 2 339 0905 | 59 377 | ||||||
| (1) | Unless otherwise indicated, one-third of the SARs are exercisable after the third anniversary of the grant date, an additional third after the fourth anniversary of the grant date and the remainder after the fifth anniversary of the grant date. All SARs must be exercised within seven years after the grant date, upon which date unexercised SARs lapse. |
| (2) | Offer price of SARs granted before December 2018 is equal to the face value on grant date. Offer price of SARs granted from December 2018 onwards is the five-day VWAP on offer date. |
| (3) | In terms of the rules of the share schemes, the offer price of SARs that were awarded prior to unbundlings, rights issues, special dividends, etc., was reduced to ensure that the participants were placed in substantially the same position as they were prior to such corporate actions. |
| (4) | This refers to the increase in value of the SARs of the indicated participants from the offer date to the date of exercise. |
| (5) | SARs offered from December 2018 onwards, have performance conditions and reflect the number of SARs as if performance conditions were fully met. |
| (6) | Fair value was calculated using the standard binomial pricing model. The estimated vesting percentage of the 2018 awards and onwards is considered to be the on-target performance level of 60%. |
| (7) | The expiry dates of these awards were extended to November 2023. As an alternative option to the 2012 SAR awards, a special award of CSPs was also made to employees. Should the employee choose to exercise his 2012 SAR award, the special CSP award will lapse. |
| (8) | The performance conditions of the 2018 awards were not met and the SARs were forfeited. |
| (9) | These awards relate to the 2019 award not made and will vest in one-thirds on the second, third and fourth anniversaries of the grant date, respectively. |
| Participant | Offer date(1) |
Offer price(2) (Rand) |
Number of SARs offered and accepted |
Fair value of SARs on offer date (R’000) |
Balance of SARs accepted as at 30 June 2020 |
Adjusted offer price(3) (Rand) |
SARs accepted/ (exercised or expired) during the year |
Share price on exercise date (Rand) |
Cash value of SARs exercised during the year(4) (R’000) |
Balance of SARs accepted as at 30 June 2021(5) |
Fair value of SARs as at 30 June 2021(6) (R’000) |
| Executive | |||||||||||
| J J Durand | 29-Nov-12(7) | 147.25 | 271 258 | 10 763 | 271 258 | 94.22 | 271 258 | 7 408 | |||
| 04-Dec-13(7) | 191.70 | 93 128 | 5 064 | 93 128 | 127.40 | 93 128 | 1 374 | ||||
| 26-Nov-14(7) | 253.53 | 108 468 | 7 442 | 108 468 | 164.57 | 108 468 | 938 | ||||
| 24-Nov-15(7) | 272.00 | 192 676 | 15 591 | 192 676 | 170.38 | 192 676 | 1 553 | ||||
| 01-Dec-16 | 209.11 | 150 872 | 10 554 | 150 872 | 125.95 | 150 872 | 2 267 | ||||
| 14-Dec-17 | 206.35 | 132 309 | 9 705 | 132 309 | 118.86 | 132 309 | 2 468 | ||||
| 05-Dec-18 | 205.07 | 87 135 | 5 436 | 87 135 | 112.38 | 87 135 | – | ||||
| 05-Dec-20(8) | 93.82 | 235 427 | 6 111 | – | 93.82 | 235 427 | 235 427 | 5 603 | |||
| 05-Dec-20 | 93.82 | 235 454 | 6 631 | – | 93.82 | 235 454 | 235 454 | 5 842 | |||
| M Lubbe | 29-Nov-12(7) | 147.25 | 13 961 | 554 | 13 961 | 94.22 | 13 961 | 381 | |||
| 04-Dec-13(7) | 191.70 | 7 444 | 405 | 7 444 | 127.40 | 7 444 | 110 | ||||
| 26-Nov-14(7) | 253.53 | 4 011 | 275 | 4 011 | 164.57 | 4 011 | 35 | ||||
| 24-Nov-15(7) | 272.00 | 8 036 | 650 | 8 036 | 170.38 | 8 036 | 65 | ||||
| 01-Dec-16 | 209.11 | 65 632 | 4 591 | 65 632 | 125.95 | 65 632 | 986 | ||||
| 14-Dec-17 | 206.35 | 15 481 | 1 136 | 15 481 | 118.86 | 15 481 | 289 | ||||
| 05-Dec-18 | 205.07 | 14 648 | 914 | 14 648 | 112.38 | 14 648 | – | ||||
| 05-Dec-20(8) | 93.82 | 39 078 | 1 014 | – | 93.82 | 39 078 | 39 078 | 930 | |||
| 05-Dec-20 | 93.82 | 46 448 | 1 308 | – | 93.82 | 46 448 | 46 448 | 1 153 | |||
| N J Williams | 29-Nov-12(7) | 147.25 | 81 901 | 3 250 | 81 901 | 94.22 | 81 901 | 2 237 | |||
| 04-Dec-13 | 191.70 | 22 221 | 1 208 | 22 221 | 127.40 | 22 221 | 328 | ||||
| 26-Nov-14 | 253.53 | 16 430 | 1 127 | 16 430 | 164.57 | 16 430 | 70 | ||||
| 24-Nov-15 | 272.00 | 27 492 | 2 225 | 27 492 | 170.38 | 27 492 | 127 | ||||
| 01-Dec-16 | 209.11 | 98 716 | 6 905 | 98 716 | 125.95 | 98 716 | 1 358 | ||||
| 14-Dec-17 | 206.35 | 55 677 | 4 084 | 55 677 | 118.86 | 55 677 | 964 | ||||
| 05-Dec-18 | 205.07 | 28 465 | 1 776 | 28 465 | 112.38 | 28 465 | – | ||||
| 05-Dec-20(8) | 93.82 | 72 103 | 1 014 | – | 93.82 | 72 103 | 72 103 | 1 716 | |||
| 05-Dec-20 | 93.82 | 72 124 | 2 031 | – | 93.82 | 72 124 | 72 124 | 1 790 | |||
| Total | 1 495 961 | 700 634 | – | 2 196 595 | 40 358 | ||||||
| (1) | Unless otherwise indicated, one-third of the SARs are exercisable after the third anniversary of the grant date, an additional third after the fourth anniversary of the grant date and the remainder after the fifth anniversary of the grant date. All SARs must be exercised within seven years after the grant date, upon which date unexercised SARs lapse. |
| (2) | Offer price of SARs granted before December 2018 is equal to the face value on grant date. Offer price of SARs granted from December 2018 onwards is the five-day VWAP on offer date. |
| (3) | In terms of the rules of the share schemes, the offer price of SARs that were awarded prior to unbundlings, rights issues, special dividends, etc., was reduced to ensure that the participants were placed in substantially the same position as they were prior to such corporate actions. |
| (4) | This refers to the increase in value of the SARs of the indicated participants from the offer date to the date of exercise. |
| (5) | SARs offered from December 2018 onwards, have performance conditions and reflect the number of SARs as if performance conditions were fully met. |
| (6) | Fair value was calculated using the standard binomial pricing model. The estimated vesting percentage of the 2018 awards and onwards is considered to be the on-target performance level of 60%. |
| (7) | The expiry dates of these awards were extended to November 2023. As an alternative option to the 2012 SAR awards, a special award of CSPs was also made to employees. Should the employee choose to exercise his 2012 SAR award, the special CSP award will lapse. |
| (8) | The performance conditions of the 2018 awards were not met and the SARs were forfeited. |
| (9) | These awards relate to the 2019 award not made and will vest in one-thirds on the second, third and fourth anniversaries of the grant date, respectively. |
| Participant | Offer date(1) |
Offer price(2) (Rand) |
Number of SARs offered and accepted |
Fair value of SARs on offer date (R’000) |
Balance of SARs accepted as at 30 June 2021 |
Adjusted offer price(3) (Rand) |
SARs accepted/ (exercised or expired) during the year |
Share price on exercise date (Rand) |
Cash value of SARs exercised during the year(4) (R’000) |
Balance of SARs accepted as at 30 June 2022(5) |
Fair value of SARs as at 30 June 2022(6) (R’000) |
| P R Louw | 29-Nov-12(7) | 147.25 | 22 646 | 899 | 22 646 | 94.22 | 22 646 | 886 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04-Dec-13(7) | 191.70 | 12 944 | 704 | 12 944 | 127.40 | 12 944 | 222 | ||||
| 26-Nov-14(7) | 253.53 | 5 952 | 408 | 5 952 | 164.57 | 5 952 | 29 | ||||
| 24-Nov-15(7) | 272.00 | 9 497 | 768 | 9 497 | 170.38 | 9 497 | 41 | ||||
| 01-Dec-16 | 209.11 | 91 120 | 6 374 | 91 120 | 125.95 | 91 120 | 1 546 | ||||
| 14-Dec-17 | 206.35 | 20 301 | 1 489 | 20 301 | 118.86 | 20 301 | 448 | ||||
| 05-Dec-18(8) | 205.07 | 17 881 | 1 116 | 17 881 | 112.38 | (17 881) | – | – | |||
| 05-Dec-20(9) | 93.82 | 46 428 | 1 205 | 46 428 | 93.82 | 46 428 | 1 462 | ||||
| 05-Dec-20 | 93.82 | 46 448 | 1 308 | 46 448 | 93.82 | 46 448 | 1 637 | ||||
| 05-Dec-21 | 126.99 | 35 796 | 1 550 | – | 126.99 | 35 796 | 35 796 | 1 058 | |||
| P J Uys | 02-Apr-13(7) | 183.15 | 218 400 | 10 519 | 218 400 | 121.67 | 218 400 | 4 732 | |||
| 04-Dec-13(7) | 191.70 | 3 325 | 181 | 3 325 | 127.40 | 3 325 | 57 | ||||
| 26-Nov-14(7) | 253.53 | 14 774 | 1 014 | 14 774 | 164.57 | 14 774 | 73 | ||||
| 24-Nov-15(7) | 272.00 | 11 533 | 933 | 11 533 | 170.38 | 11 533 | 49 | ||||
| 01-Dec-16 | 209.11 | 91 463 | 6 398 | 91 463 | 125.95 | 91 463 | 1 552 | ||||
| 14-Dec-17 | 206.35 | 85 936 | 6 303 | 85 936 | 118.86 | 85 936 | 1 895 | ||||
| 05-Dec-18(8) | 205.07 | 35 822 | 2 235 | 35 822 | 112.38 | (35 822) | – | – | |||
| 05-Dec-20(9) | 93.82 | 88 088 | 2 286 | 88 088 | 93.82 | 88 088 | 2 774 | ||||
| 05-Dec-20 | 93.82 | 88 108 | 2 481 | 88 108 | 93.82 | 88 108 | 3 106 | ||||
| 05-Dec-21 | 126.99 | 67 853 | 2 938 | – | 126.99 | 67 853 | 67 853 | 2 006 | |||
| Total | 910 666 | 49 946 | – | 960 612 | 23 573 | ||||||
| (1) | Unless otherwise indicated, one-third of the SARs are exercisable after the third anniversary of the grant date, an additional third after the fourth anniversary of the grant date and the remainder after the fifth anniversary of the grant date. All SARs must be exercised within seven years after grant date, upon which date unexercised SARs lapse. |
| (2) | Offer price of SARs granted before December 2018 is equal to the face value on grant date. Offer price of SARs granted from December 2018 onwards is the five-day VWAP on offer date. |
| (3) | In terms of the rules of the share schemes, the offer price of SARs that were awarded prior to unbundlings, rights issues, special dividends, etc., was reduced to ensure that the participants were placed in substantially the same position as they were prior to such corporate actions. |
| (4) | This refers to the increase in value of the SARs from the offer date to the date of exercise. |
| (5) | SARs offered from December 2018 onwards, have performance conditions and reflect the number of SARs as if performance conditions were fully met. |
| (6) | Fair value was calculated using the standard binomial pricing model. The estimated vesting percentage of the 2018 awards and onwards is considered to be the on-target performance level of 60%. |
| (7) | The expiry dates of these awards were extended to November 2023. As an alternative option to the 2012 SAR awards, a special award of CSPs was also made to employees. Should the employee choose to exercise the 2012 SAR award, the special CSP award will lapse. |
| (8) | The performance conditions of the 2018 awards were not met and the SARs were forfeited. |
| (9) | These awards relate to the 2019 award not made and will vest in one-thirds on the second, third and fourth anniversaries of the grant date, respectively. |
| Participant | Offer date(1) |
Offer price(2) (Rand) |
Number of SARs offered and accepted |
Fair value of SARs on offer date (R’000) |
Balance of SARs accepted as at 30 June 2020 |
Adjusted offer price(3) (Rand) |
SARs accepted/ (exercised or expired) during the year |
Share price on exercise date (Rand) |
Cash value of SARs exercised during the year(4) (R’000) |
Balance of SARs accepted as at 30 June 2021(5) |
Fair value of SARs as at 30 June 2021(6) (R’000) |
| P R Louw | 29-Nov-12(7) | 147.25 | 22 646 | 899 | 22 646 | 94.22 | 22 646 | 618 | |||
| 04-Dec-13(7) | 191.70 | 12 944 | 704 | 12 944 | 127.40 | 12 944 | 191 | ||||
| 26-Nov-14(7) | 253.53 | 5 952 | 408 | 5 952 | 164.57 | 5 952 | 51 | ||||
| 24-Nov-15(7) | 272.00 | 9 497 | 768 | 9 497 | 170.38 | 9 497 | 77 | ||||
| 01-Dec-16 | 209.11 | 91 120 | 6 374 | 91 120 | 125.95 | 91 120 | 1 369 | ||||
| 14-Dec-17 | 206.35 | 20 301 | 1 489 | 20 301 | 118.86 | 20 301 | 379 | ||||
| 05-Dec-18 | 205.07 | 17 881 | 1 116 | 17 881 | 112.38 | 17 881 | – | ||||
| 05-Dec-20(8) | 93.82 | 46 428 | 1 205 | – | 93.82 | 46 428 | 46 428 | 1 105 | |||
| 05-Dec-20 | 93.82 | 46 448 | 1 308 | – | 93.82 | 46 448 | 46 448 | 1 153 | |||
| P J Uys | 02-Apr-13(7) | 183.15 | 218 400 | 10 519 | 218 400 | 121.67 | 218 400 | 3 868 | |||
| 04-Dec-13(7) | 191.70 | 3 325 | 181 | 3 325 | 127.40 | 3 325 | 49 | ||||
| 26-Nov-14(7) | 253.53 | 14 774 | 1 014 | 14 774 | 164.57 | 14 774 | 128 | ||||
| 24-Nov-15(7) | 272.00 | 11 533 | 933 | 11 533 | 170.38 | 11 533 | 93 | ||||
| 01-Dec-16 | 209.11 | 91 463 | 6 398 | 91 463 | 125.95 | 91 463 | 1 374 | ||||
| 14-Dec-17 | 206.35 | 85 936 | 6 303 | 85 936 | 118.86 | 85 936 | 1 603 | ||||
| 05-Dec-18 | 205.07 | 35 822 | 2 235 | 35 822 | 112.38 | 35 822 | – | ||||
| 05-Dec-20(8) | 93.82 | 88 088 | 2 286 | – | 93.82 | 88 088 | 88 088 | 2 096 | |||
| 05-Dec-20 | 93.82 | 88 108 | 2 481 | – | 93.82 | 88 108 | 88 108 | 2 186 | |||
| Total | 641 594 | 269 072 | – | 910 666 | 16 340 | ||||||
| (1) | Unless otherwise indicated, one-third of the SARs are exercisable after the third anniversary of the grant date, an additional third after the fourth anniversary of the grant date and the remainder after the fifth anniversary of the grant date. All SARs must be exercised within seven years after grant date, upon which date unexercised SARs lapse. |
| (2) | Offer price of SARs granted before December 2018 is equal to the face value on grant date. Offer price of SARs granted from December 2018 onwards is the five-day VWAP on offer date. |
| (3) | In terms of the rules of the share schemes, the offer price of SARs that were awarded prior to unbundlings, rights issues, special dividends, etc., was reduced to ensure that the participants were placed in substantially the same position as they were prior to such corporate actions. |
| (4) | This refers to the increase in value of the SARs from the offer date to the date of exercise. |
| (5) | SARs offered from December 2018 onwards, have performance conditions and reflect the number of SARs as if performance conditions were fully met. |
| (6) | Fair value was calculated using the standard binomial pricing model. The estimated vesting percentage of the 2018 awards and onwards is considered to be the on-target performance level of 60%. |
| (7) | The expiry dates of these awards were extended to November 2023. As an alternative option to the 2012 SAR awards, a special award of CSPs was also made to employees. Should the employee choose to exercise the 2012 SAR award, the special CSP award will lapse. |
| (8) | The performance conditions of the 2018 awards were not met and the SARs were forfeited. |
| (9) | These awards relate to the 2019 award not made and will vest in one-thirds on the second, third and fourth anniversaries of the grant date, respectively. |
The tables below provide information on a director and prescribed officer basis of CSPs granted and accepted during the year. It also illustrates the cash value of CSPs vested during the year.
| Participant | Offer date(1) |
Offer price(2) (Rand) |
Number of CSPs offered and accepted |
Fair value of CSPs on offer date (R’000) |
Balance of CSPs accepted as at 30 June 2021 |
CSPs accepted/ (exercised or expired) during the year |
Share price on vesting date(3) (Rand) |
Cash value of CSPs vesting in year(4) (R’000) |
Balance of CSPs accepted as at 30 June 2022(5, 6) |
Fair value of CSPs as at 30 June 2022(7) (R’000) |
| Executive | ||||||||||
| J J Durand | 05-Dec-18(8) | 205.07 | 120 107 | 15 933 | 120 107 | (120 107) | – | – | ||
| 05-Dec-20(9) | 93.82 | 235 427 | 20 366 | 235 427 | 235 427 | 17 970 | ||||
| 05-Dec-20 | 93.82 | 235 454 | 19 655 | 235 454 | 235 454 | 17 644 | ||||
| 05-Dec-20(10) | 93.82 | 95 672 | 8 728 | 95 672 | 95 672 | 6 198 | ||||
| 05-Dec-21 | 126.99 | 181 379 | 20 747 | – | 181 379 | 181 379 | 13 344 | |||
| M Lubbe | 05-Dec-18(8) | 205.07 | 20 191 | 2 678 | 20 191 | (20 191) | – | – | ||
| 05-Dec-20(9) | 93.82 | 39 078 | 3 380 | 39 078 | 39 078 | 2 983 | ||||
| 05-Dec-20 | 93.82 | 46 448 | 3 877 | 46 448 | 46 448 | 3 481 | ||||
| 05-Dec-20(10) | 93.82 | 4 924 | 449 | 4 924 | 4 924 | 319 | ||||
| 05-Dec-21 | 126.99 | 35 796 | 4 094 | – | 35 796 | 35 796 | 2 634 | |||
| N J Williams | 05-Dec-18(8) | 205.07 | 39 237 | 5 205 | 39 237 | (39 237) | – | – | ||
| 05-Dec-20(9) | 93.82 | 72 103 | 6 237 | 72 103 | 72 103 | 5 503 | ||||
| 05-Dec-20 | 93.82 | 72 124 | 6 021 | 72 124 | 72 124 | 5 405 | ||||
| 05-Dec-20(10) | 93.82 | 28 887 | 2 635 | 28 887 | 28 887 | 1 871 | ||||
| 05-Dec-21 | 126.99 | 55 568 | 6 356 | – | 55 568 | 55 568 | 4 088 | |||
| Total | 1 009 652 | 93 208 | – | 1 102 860 | 81 440 | |||||
| (1) | Unless otherwise indicated, one-third of the CSPs vest, after the third anniversary of the grant date, an additional third after the fourth anniversary of the grant date and the remainder after the fifth anniversary of the grant date. |
| (2) | Offer price of CSPs granted is the five-day VWAP on offer date. |
| (3) | Five-day VWAP of Remgro on vesting date. |
| (4) | This refers to the total value of the CSPs on vesting. |
| (5) | CSPs have performance conditions and reflect the number of CSPs as if performance conditions were fully met. |
| (6) | Dividend equivalents will be accumulated and delivered in shares upon vesting. |
| (7) | Fair value was calculated using the standard binomial pricing model. The estimated vesting percentage is considered to be the on-target performance level of 60%. The special award of CSPs (refer below) does not have performance conditions. |
| (8) | The performance conditions of the 2018 awards were not met and the CSPs were forfeited. |
| (9) | These awards relate to the 2019 award not made and will vest in one-thirds on the second, third and fourth anniversaries of the grant date, respectively. |
| (10) | As an alternative to the 2012 SAR awards, this special award of CSPs was also made to employees. Should the employee choose to exercise the 2012 SAR award, this special CSP award will lapse. |
| Participant | Offer date(1) |
Offer price(2) (Rand) |
Number of CSPs offered and accepted |
Fair value of CSPs on offer date (R’000) |
Balance of CSPs accepted as at 30 June 2020 |
CSPs accepted/ (exercised or expired) during the year |
Share price on vesting date(3) (Rand) |
Cash value of CSPs vesting in year(4) (R’000) |
Balance of CSPs accepted as at 30 June 2021(5, 6) |
Fair value of CSPs as at 30 June 2021(7) (R’000) |
| Executive | ||||||||||
| J J Durand | 05-Dec-18 | 205.07 | 120 107 | 15 933 | 120 107 | 120 107 | – | |||
| 05-Dec-20(8) | 93.82 | 235 427 | 20 366 | – | 235 427 | 235 427 | 15 000 | |||
| 05-Dec-20 | 93.82 | 235 454 | 19 655 | – | 235 454 | 235 454 | 14 520 | |||
| 05-Dec-20(9) | 93.82 | 95 672 | 8 728 | – | 95 672 | 95 672 | 10 666 | |||
| M Lubbe | 05-Dec-18 | 205.07 | 20 191 | 2 678 | 20 191 | 20 191 | – | |||
| 05-Dec-20(8) | 93.82 | 39 078 | 3 380 | – | 39 078 | 39 078 | 2 490 | |||
| 05-Dec-20 | 93.82 | 46 448 | 3 877 | – | 46 448 | 46 448 | 2 846 | |||
| 05-Dec-20(9) | 93.82 | 4 924 | 449 | – | 4 924 | 4 924 | 549 | |||
| N J Williams | 05-Dec-18 | 205.07 | 39 237 | 5 205 | 39 237 | 39 237 | – | |||
| 05-Dec-20(8) | 93.82 | 72 103 | 6 237 | – | 72 103 | 72 103 | 4 594 | |||
| 05-Dec-20 | 93.82 | 72 124 | 6 021 | – | 72 124 | 72 124 | 4 448 | |||
| 05-Dec-20(9) | 93.82 | 28 887 | 2 635 | – | 28 887 | 28 887 | 3 220 | |||
| Total | 179 535 | 830 117 | – | 1 009 652 | 58 351 | |||||
| (1) | Unless otherwise indicated, one-third of the CSPs vest, after the third anniversary of the grant date, an additional third after the fourth anniversary of the grant date and the remainder after the fifth anniversary of the grant date. |
| (2) | Offer price of CSPs granted is the five-day VWAP on offer date. |
| (3) | Five-day VWAP of Remgro on vesting date. |
| (4) | This refers to the total value of the CSPs on vesting. |
| (5) | CSPs have performance conditions and reflect the number of CSPs as if performance conditions were fully met. |
| (6) | Dividend equivalents will be accumulated and delivered in shares upon vesting. |
| (7) | Fair value was calculated using the standard binomial pricing model. The estimated vesting percentage is considered to be the on-target performance level of 60%. The special award of CSPs (refer below) does not have performance conditions. It is also estimated that the performance conditions of the 2018 award will not be met. |
| (8) | These awards relate to the 2019 award not made and will vest in one-thirds on the second, third and fourth anniversaries of the grant date, respectively. |
| (9) | As an alternative to the 2012 SAR awards, this special award of CSPs was also made to employees. Should the employee choose to exercise the 2012 SAR award, this special CSP award will lapse. |
| Participant | Offer date(1) |
Offer price(2) (Rand) |
Number of CSPs offered and accepted |
Fair value of CSPs on offer date (R’000) |
Balance of CSPs accepted as at 30 June 2021 |
CSPs accepted/ (exercised or expired) during the year |
Share price on vesting date(3) (Rand) |
Cash value of CSPs vesting in year(4) (R’000) |
Balance of CSPs accepted as at 30 June 2022(5, 6) |
Fair value of CSPs as at 30 June 2022(7) (R’000) |
| P R Louw | 05-Dec-18(8) | 205.07 | 24 648 | 3 270 | 24 648 | (24 648) | - | – | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 05-Dec-20(9) | 93.82 | 46 428 | 4 016 | 46 428 | 46 428 | 3 544 | ||||
| 05-Dec-20 | 93.82 | 46 448 | 3 877 | 46 448 | 46 448 | 3 481 | ||||
| 05-Dec-20(10) | 93.82 | 7 988 | 729 | 7 988 | 7 988 | 518 | ||||
| 05-Dec-21 | 126.99 | 35 796 | 4 094 | – | 35 796 | 35 796 | 2 634 | |||
| P J Uys | 05-Dec-18(8) | 205.07 | 49 378 | 6 550 | 49 378 | (49 378) | 49 378 | – | ||
| 05-Dec-20(9) | 93.82 | 88 088 | 7 620 | 88 088 | 88 088 | 6 724 | ||||
| 05-Dec-20 | 93.82 | 88 108 | 7 355 | 88 108 | 88 108 | 6 602 | ||||
| 05-Dec-21 | 126.99 | 67 853 | 7 761 | – | 67 853 | 67 853 | 4 992 | |||
| Total | 351 086 | 29 623 | – | 380 709 | 28 495 | |||||
| (1) | Unless otherwise indicated, one-third of the CSPs vest, after the third anniversary of the grant date, an additional third after the fourth anniversary of the grant date and the remainder after the fifth anniversary of the grant date. |
| (2) | Offer price of CSPs granted is the five-day VWAP on offer date. |
| (3) | Five-day VWAP of Remgro on vesting date. |
| (4) | This refers to the total value of the CSPs on vesting. |
| (5) | CSPs have performance conditions and reflect the number of CSPs as if performance conditions were fully met. |
| (6) | Dividend equivalents will be accumulated and delivered in shares upon vesting. |
| (7) | Fair value was calculated using the standard binomial pricing model. The estimated vesting percentage is considered to be the on-target performance level of 60%. The special award of CSPs (refer below) does not have performance conditions. It is also estimated that the performance conditions of the 2018 award will not be met. |
| (8) | These awards relate to the 2019 award not made and will vest in one-thirds on the second, third and fourth anniversaries of the grant date, respectively. |
| (9) | As an alternative to the 2012 SAR awards, this special award of CSPs was also made to employees. Should the employee choose to exercise the 2012 SAR award, this special CSP award will lapse. |
| (10) | As an alternative to the 2012 SAR awards, this special award of CSPs was also made to employees. Should the employee choose to exercise the 2012 SAR award, this special CSP award will lapse. |
| Participant | Offer date(1) |
Offer price(2) (Rand) |
Number of CSPs offered and accepted |
Fair value of CSPs on offer date (R’000) |
Balance of CSPs accepted as at 30 June 2020 |
CSPs accepted/ (exercised or expired) during the year |
Share price on vesting date(3) (Rand) |
Cash value of CSPs vesting in year(4) (R’000) |
Balance of CSPs accepted as at 30 June 2021(5, 6) |
Fair value of CSPs as at 30 June 2021(7) (R’000) |
| P R Louw | 05-Dec-18 | 205.07 | 24 648 | 3 270 | 24 648 | 24 648 | – | |||
| 05-Dec-20(8) | 93.82 | 46 428 | 4 016 | – | 46 428 | 46 428 | 2 958 | |||
| 05-Dec-20 | 93.82 | 46 448 | 3 877 | – | 46 448 | 46 448 | 2 864 | |||
| 05-Dec-20(9) | 93.82 | 7 988 | 729 | – | 7 988 | 7 988 | 891 | |||
| P J Uys | 05-Dec-18 | 205.07 | 49 378 | 6 550 | 49 378 | 49 378 | – | |||
| 05-Dec-20(8) | 93.82 | 88 088 | 7 620 | – | 88 088 | 88 088 | 5 612 | |||
| 05-Dec-20 | 93.82 | 88 108 | 7 355 | – | 88 108 | 88 108 | 5 434 | |||
| Total | 74 026 | 277 060 | – | 351 086 | 17 759 | |||||
| (1) | Unless otherwise indicated, one-third of the CSPs vest, after the third anniversary of the grant date, an additional third after the fourth anniversary of the grant date and the remainder after the fifth anniversary of the grant date. |
| (2) | Offer price of CSPs granted is the five-day VWAP on offer date. |
| (3) | Five-day VWAP of Remgro on vesting date. |
| (4) | This refers to the total value of the CSPs on vesting date. |
| (5) | CSPs have performance conditions and reflect the number of CSPs as if performance conditions were fully met. |
| (6) | Dividend equivalents will be accumulated and delivered in shares upon vesting. |
| (7) | Fair value was calculated using the standard binomial pricing model. The estimated vesting percentage is considered to be the on-target performance level of 60%. The special award of CSPs (refer below) does not have performance conditions. It is also estimated that the performance conditions of the 2018 award will not be met. |
| (8) | These awards relate to the 2019 award not made and will vest in one-thirds on the second, third and fourth anniversaries of the grant date, respectively. |
| (9) | As an alternative to the 2012 SAR awards, this special award of CSPs was also made to employees. Should the employee choose to exercise the 2012 SAR award, this special CSP award will lapse. Refer here for more context. |
Linking pay with the delivery of long-term shareholder value
The graph above illustrates the following:
| 1. | LTI intrinsic value vested – The stacked columns represent the intrinsic value that vested (for SARs and CSPs) to the CEO as at the end of each reporting period. With regards to the SARs, it should be noted that the awards vesting in 2018 to 2020 had no performance conditions attached (other than the inherent condition for share price growth above the award price) and as a result the vesting outcome was 100%. However, these awards were underwater as at the end of their respective financial years (i.e. the share price at year-end was below the award price) and as a result the intrinsic value of these awards amount to Rnil which resulted in no value vesting at the reporting date for these awards. The SARs vesting in years 2021 and 2022 had performance conditions attached and the vesting outcomes for these awards were 0% and 75% respectively. As a result, a value of Rnil vested in 2021, while in 2022 the total value vested amounts to R6.4 million, with one-third vesting immediately (R2.1 million) and the two-thirds remaining (R4.3 million) vesting in equal tranches over the next two years. With regards to the CSPs, the CSPs vesting outcomes in 2021 and 2022 were 0% and 75% respectively. As a result, a value of Rnil vesting in 2021, while in 2022 the total value vested amounts to R22.9 million, with one-third vesting immediately (R7.7 million) and the two-thirds remaining (R15.3 million) vesting in equal tranches over the next two years. Please note that the SARs and CSPs vesting in 2022 were awarded in 2020 and as a result these had a reduced performance period of two years instead of three years. This is due to the fact that no awards were made in 2019 as a result of the impacts of Covid-19, and as a result these allocations were only made in 2020. |
| 2. | TSR performance over the performance period – Overlaid to the value vested graph is a line graph which represents the TSR Compound Annual Growth Rate (CAGR) performance outcome that was achieved during the performance period for each of the awards. As a result, for the awards vesting in years 2018 to 2021 the TSR represents a three-year CAGR outcome, whereas due to the fact that the awards vesting in 2022 were only awarded in 2020 (as noted above), the TSR outcome for 2022 represents a twoyear TSR CAGR in order to align with the performance period of the awards. In interpreting the outcomes of the graph, it can be seen that there is alignment between the CEO vesting outcomes and shareholder value creation.
|
The tables below provide information on the single figure remuneration for executive directors and prescribed officers, which comprises a fixed annual amount, as well as the value of the shares vesting 12 months after year-end.
| R’000 | Fees | Salaries | Retirement fund |
Other benefits(1) |
Fixed remuneration |
LTI(2) | Total | |||
| 30 June 2022 | ||||||||||
| J J Durand | 390 | 12 107 | 2 479 | 419 | 15 395 | 9 682 | 25 077 | |||
| M Lubbe | 390 | 2 647 | 602 | 431 | 4 070 | 1 583 | 5 653 | |||
| N J Williams | 390 | 4 509 | 965 | 423 | 6 287 | 3 021 | 9 308 | |||
| Total | 1 170 | 19 263 | 4 046 | 1 273 | 25 752 | 14 286 | 40 038 | |||
| 30 June 2021 | ||||||||||
| J J Durand | 390 | 11 596 | 2 377 | 411 | 14 804 | – | 14 804 | |||
| M Lubbe | 390 | 2 327 | 535 | 412 | 3 664 | – | 3 664 | |||
| N J Williams | 390 | 4 309 | 932 | 404 | 6 035 | – | 6 035 | |||
| Total | 1 170 | 18 232 | 3 844 | 1 257 | 24 503 | – | 24 503 | |||
| (1) | Benefits include medical scheme contributions, vehicle benefits and UIF contributions. |
| (2) | LTI figure includes SARs and CSPs awards that vest and become exercisable in the next 12 months. |
| R’000 | Salaries | Retirement fund |
Other benefits(1) |
Fixed remuneration |
LTI(2) | Total | ||||
| 30 June 2022 | ||||||||||
| P R Louw | 3 037 | 598 | 432 | 4 067 | 1 886 | 5 953 | ||||
| P J Uys | 6 074 | 1 196 | 387 | 7 657 | 3 755 | 11 412 | ||||
| Total | 9 111 | 1 764 | 819 | 11 724 | 5 641 | 17 365 | ||||
| 30 June 2021 | ||||||||||
| P R Louw | 2 912 | 578 | 412 | 3 902 | – | 3 902 | ||||
| P J Uys | 5 828 | 1 156 | 384 | 7 368 | – | 7 368 | ||||
| Total | 8 740 | 1 734 | 796 | 11 270 | – | 11 270 | ||||
| (1) | Benefits include medical scheme contributions, vehicle benefits and UIF contributions. |
| (2) | LTI figure includes SARs and CSPs awards that vest and become exercisable in the next 12 months. |
The actual fees paid to non-executive directors are disclosed below (on an individual basis).
| R’000 | Fee for the year ended 30 June 2022 |
Fee for the year ended 30 June 2021 |
|
| Non-executive (independent) | |||
| S E N De Bruyn(1) | 972 | 791 | |
| P K Harris(2) | - | 227 | |
| N P Mageza(3) | 620 | 678 | |
| P J Moleketi | 620 | 678 | |
| M Morobe(4) | 580 | 510 | |
| G G Nieuwoudt | 480 | 390 | |
| K S Rantloane(5) | 540 | 228 | |
| F Robertson | 680 | 603 | |
| Subtotal | 4 492 | 4 105 | |
| Non-executive (non-independent) | |||
| J Malherbe | 480 | 390 | |
| P J Neethling(6) | – | – | |
| A E Rupert(6) | – | – | |
| J P Rupert(6) | – | – | |
| Subtotal | 480 | 395 | |
| Total | 4 972 | 4 495 | |
| (1) | Ms S E N De Bruyn was appointed as a member of the Remuneration and Nomination Committee with effect from 30 November 2020. |
| (2) | Mr P K Harris retired as independent non-executive director with effect from 30 November 2020. |
| (3) | During the year under review Mr N P Mageza also received R772 000 (2021: R746 000) as director’s fees from RCL Foods Limited, a subsidiary of Remgro Limited. |
| (4) | During the year under review Mr M Morobe also received R150 000 as director’s fees from Wispeco Holdings Proprietary Limited, a subsidiary of Remgro Limited. |
| (5) | Mr K S Rantloane was appointed as an independent non-executive director and member of the Investment Committee with effect from 30 November 2020. |
| (6) | Messrs A E Rupert, J P Rupert and P J Neethling receive no emoluments. |
![]()
Johann Rupert
Chairman of the Remuneration and Nomination Committee
Stellenbosch
26 September 2022